Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roniciclib + Chemo in ED-SCLC
NCT01573338Phase 2Terminated
- Sponsor
- Bayer
- Start
- Feb 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of roniciclib in small cell lung cancer (SCLC), sponsored by Bayer. Started Feb 2013; status: terminated.
02
Drugs
roniciclib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT01573338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573338.